Media 01
I helped negotiate Trump’s trade deal. He can now fix what Pelosi broke
Lawmakers must reject I-MAK’s questionable data and abandon two damaging bills, the Drug Competition Enhancement Act and Affordable Prescriptions for Patients Act.
Congress should base patent policy on evidence, not accusations
Lawmakers must reject I-MAK’s questionable data and abandon two damaging bills, the Drug Competition Enhancement Act and Affordable Prescriptions for Patients Act.
Council for Innovation Promotion Statement on the USPTO’s Revised Inventorship Guidance for AI-Assisted Inventions
WASHINGTON (December 1, 2025) — On Wednesday, November 26, 2025, the U.S. Patent and Trademark Office (USPTO) announced a Federal Register notice establishing the USPTO’s
Council for Innovation Promotion Statement on RALIA and the BIA
WASHINGTON (November 10, 2025) — Recently, Representatives Thomas Massie (R-KY), Marcy Kaptur (D-OH), Michael Cloud (R-TX), Warren Davidson (R-OH), Paul Gosar (R-AZ), and Chip Roy
Council for Innovation Promotion Urges Caution Regarding I-MAK’s New Report on Patents and Drug Pricing
WASHINGTON (October 20, 2025) — Today, the Council for Innovation Promotion (C4IP) Executive Director Frank Cullen released the following statement regarding a new report from